chronic disease

Health Elizabeth Cooney

Dietary guidelines panel stresses fruits and vegetables but stops shy of major changes 

Health Elizabeth Cooney

Dietary experts advise skipping guidelines on ultra-processed foods — for now

Health Elizabeth Cooney

STAT Plus: Q&A: FDA chief on why our hearts are less healthy, how obesity drugs impress him, and what worries him

Special Report Elizabeth Cooney

11 experts on why gains in cardiovascular disease are stalling and what we can do about it

Special Report Elizabeth Cooney

Heart disease experts in their own words: ‘This is solvable and this is preventable’

Biotech Jonathan Wosen

STAT Plus: Jasper, looking to rival Genentech and Novartis’ Xolair, reports positive data for skin condition drug

Health Elizabeth Cooney

In children, Covid is tied to higher risk of type 2 diabetes 

Biotech Allison DeAngelis

STAT Plus: Chasing CAR-T, biotech finds its next gold rush in autoimmune disease

Pharma Katie Palmer

STAT Plus: In stark reversal, FDA to reconsider removal of Eli Lilly weight loss drug from shortage list

Health Elaine Chen

STAT Plus: As Eli Lilly, compounders battle over weight loss drugs, patients are caught in the middle

Exclusive Isabella Cueto

With boost from RFK Jr. and Tucker Carlson, two chronic disease entrepreneurs vault into Trump’s orbit

Morning Rounds Theresa Gaffney

Morning Rounds: Women with sickle cell are sterilized postpartum more than others

Health Eric Boodman

Sickle cell community scrambles to find safe plan after a drug is pulled from the market

Pharma Matthew Herper, Eric Boodman, Andrew Joseph, Lizzy Lawrence, Adam Feuerstein, and Jason Mast

STAT Plus: What the withdrawal of its sickle cell drug means for Pfizer, patients, and the FDA

Biotech Elaine Chen

STAT Plus: AbbVie Parkinson’s drug helps improve symptoms in late-stage study

Health Lev Facher

Ozempic linked to lower opioid overdose rate in those with diabetes, study shows

Biotech Andrew Joseph

STAT Plus: Celldex drug reduces chronic hive activity, but patient discontinuations raise questions

Biotech Adam Feuerstein

STAT Plus: Risky bet by Biogen and UCB on systemic lupus drug appears to pay off, data show

Exclusive Kate Raphael

Pediatricians’ obesity guidelines rest on shaky evidence about eating disorder risks

Pharma Jonathan Wosen

STAT Plus: FDA approves Roche’s injectable version of blockbuster multiple sclerosis drug

Politics Isabella Cueto and Sarah Owermohle

STAT Plus: After decades of anti-vaccine rhetoric, RFK Jr. pivots to chronic diseases — and gets Trump on board

Morning Rounds Theresa Gaffney

Is the GLP-1 party running down for Hims, and a study for the weekend

Morning Rounds Theresa Gaffney

Glucose monitors, mpox vaccine inequity and effects of LGBTQ+ restrictions

Health tech Katie Palmer and Lizzy Lawrence

STAT Plus: Continuous glucose monitoring for the masses is here. Are we ready for it?

Morning Rounds Isabella Cueto

FDA approves latest Covid vaccines, and Harris makes her case

First Opinion Kaitlin Costello

Mask bans disenfranchise millions of Americans with disabilities

Morning Rounds Theresa Gaffney

New Medicare drug prices, antimicrobial-resistant meningitis, unlucky American women

Health Elizabeth Cooney

Sudden cardiac arrest requires luck to survive. Scientists hope to turn those odds around

Morning Rounds Brittany Trang

Morning Rounds: Getting healthier in the checkout aisle and the alcohol aisle